Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
ClinicalTrials.gov study NCT03279250. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer
ClinicalTrials.gov study NCT03451162. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
ClinicalTrials.gov study NCT00598442. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
ClinicalTrials.gov study NCT04501666. IPD Sharing: YES. Countries: 10. Publications: 3.
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT03361956. IPD Sharing: Not stated. Countries: 19. Publications: 3.
Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants
ClinicalTrials.gov study NCT04863417. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
ClinicalTrials.gov study NCT00642941. IPD Sharing: YES. Countries: 11. Publications: 2.
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
ClinicalTrials.gov study NCT04432831. IPD Sharing: YES. Countries: 30. Publications: 1.
A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT03488030. IPD Sharing: YES. Countries: 1. Publications: 1.
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00751881. IPD Sharing: Not stated. Countries: 26. Publications: 6.
Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy
ClinicalTrials.gov study NCT03514914. IPD Sharing: Not stated. Countries: 1. Publications: 10.
A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biolog
ClinicalTrials.gov study NCT03345849. IPD Sharing: YES. Countries: 49. Publications: 7.
A Study of NGM621 in Participants With Geographic Atrophy
ClinicalTrials.gov study NCT04465955. IPD Sharing: NO. Countries: 1. Publications: 1.
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
ClinicalTrials.gov study NCT00981058. IPD Sharing: Not stated. Countries: 26. Publications: 4.
A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
ClinicalTrials.gov study NCT03606460. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
ClinicalTrials.gov study NCT05069896. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Baricitinib (LY3009104) in Participants With COVID-19
ClinicalTrials.gov study NCT04421027. IPD Sharing: YES. Countries: 13. Publications: 3.
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
ClinicalTrials.gov study NCT00532129. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01564537. IPD Sharing: Not stated. Countries: 2. Publications: 8.
A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
ClinicalTrials.gov study NCT02277691. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.